Skip to main content
Fig. 18 | Insights into Imaging

Fig. 18

From: Primary myelofibrosis: spectrum of imaging features and disease-related complications

Fig. 18

18F-FLT PET in a patient with myelofibrosis demonstrating diffuse increased tracer uptake in the bones and enlarged spleen. 18F-FLT PET is an excellent alternative to FDG due to the ability to directly assess myeloproliferative activity without the superimposed inflammatory component of disease. 18F-FLT PET can also be used to determine disease status or treatment outcome when performed at baseline

Back to article page